Sara Mcgee, M.D.
NPI 1437144409 · Hematology & Oncology Physician · West Reading, PA
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Sara Mcgee, M.D. is a Hematology & Oncology Physician provider in West Reading, PA (NPI 1437144409).
Provider details
- NPI number
- 1437144409
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- MA047382 (NJ)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
368 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 174 | $97 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 113 | $66 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 50 | $132 |
| Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223 | 16 | $176 |
| Telephone Medical Discussion With Physician, 5-10 Minutes99441 | 15 | $35 |
Typical Medicare-allowed amounts for these services range $35–$176 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Anastrozole | 39 | 14 |
| Apixabanbrand: Eliquis | 25 | — |
| Oxycodone Hcl | 19 | — |
| Hydroxyurea | 15 | — |
| Letrozole | 14 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$85 across 4 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 368 Lakehurst RdSuite 201Toms River, NJ 08755-7339Phone: (732) 505-1500Fax: (732) 505-1520
Registry dates
- Enumerated
- 2005-09-15
- Last updated
- 2024-04-26
- Certified
- 2024-04-26
Frequently asked questions
- What is Sara Mcgee's NPI number?
- Sara Mcgee's National Provider Identifier (NPI) is 1437144409, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Sara Mcgee's specialty?
- Sara Mcgee is listed in the NPPES registry with a primary specialty of Hematology & Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Sara Mcgee located?
- Sara Mcgee's practice location on file with NPPES is 420 S 5th Ave Bldg N, West Reading, PA 19611-2143.
- What is Sara Mcgee's phone number?
- The practice phone number listed in the NPPES registry for Sara Mcgee is (484) 628-0900.
- Does Sara Mcgee accept Medicare?
- Sara Mcgee is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Sara Mcgee's NPI active?
- Yes — Sara Mcgee's NPI (1437144409) is active in the NPPES registry as of the last update on 2024-04-26.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.